Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Thoraxerweiterung vs. DNS-Übungen bei HWS-Syndrom (FHP-DNS-TE)

4. November 2026 aktualisiert von: Esra BECENI, Bahçeşehir University

Eine randomisierte kontrollierte Studie zum Vergleich von thorakalen Expansionübungen und dynamischer neuromuskulärer Stabilisierung auf die Atemfunktion und bilaterale Trapezius-Muskelaktivität bei Personen mit Vorwärtskopfhaltung

This randomized controlled trial aims to compare the effects of thoracic expansion exercises and Dynamic Neuromuscular Stabilization (DNS) on respiratory function and bilateral trapezius muscle activity in individuals with forward head posture (FHP). A total of 32 participants aged 18-40 years with a craniovertebral angle (CVA) of less than 53° will be randomly assigned to either the DNS group or the thoracic expansion exercise group. Primary outcomes include respiratory function (FEV1, FVC, FEV1/FVC), trapezius muscle activation measured with EMG biofeedback, and craniovertebral angle. Secondary outcomes include thoracic mobility and health-related quality of life assessed using the St. George's Respiratory Questionnaire. Both interventions will be applied for 6 weeks. The study aims to determine which approach provides greater improvement in posture-related respiratory dysfunction and muscle activation.

Studienübersicht

Detaillierte Beschreibung

Forward head posture (FHP) is a common postural deviation characterized by reduced craniovertebral angle (CVA), altered cervicothoracic alignment, and compensatory activation of accessory respiratory muscles. Individuals with FHP frequently demonstrate limited thoracic mobility, decreased respiratory efficiency, and increased demand on superficial neck musculature. These biomechanical alterations may negatively influence pulmonary function parameters such as FEV1 and FVC, as well as contribute to elevated electromyographic (EMG) activity in the upper trapezius muscles.

Various therapeutic approaches have been developed to address posture-related respiratory dysfunction. Thoracic expansion breathing exercises aim to enhance chest wall mobility and improve lung expansion across upper, middle, and lower thoracic regions. Dynamic Neuromuscular Stabilization (DNS), based on developmental kinesiology principles, seeks to optimize diaphragmatic function, intra-abdominal pressure regulation, and coordinated activation of deep stabilizing musculature. Although both methods have theoretical benefits for improving respiratory mechanics and postural alignment, comparative evidence regarding their differential effects in individuals with FHP remains limited.

This randomized controlled trial will investigate the immediate and short-term effects of thoracic expansion breathing exercises versus DNS-based stabilization exercises on respiratory function, cervicothoracic posture, and muscle activation patterns. Thirty-two adults aged 18-40 years with a CVA of less than 53° will be enrolled and randomly assigned using an opaque envelope method to one of two intervention groups: the Thoracic Expansion Exercise Group or the Dynamic Neuromuscular Stabilization Group. Each intervention protocol will be implemented over a 6-week period, consisting of twice-weekly supervised sessions complemented by twice-daily home exercise routines.

Outcome assessments will be conducted at baseline and at the end of the 6-week intervention period. These assessments will include: CVA measured by standardized lateral photography and ImageJ analysis; bilateral upper trapezius muscle activity assessed using surface EMG biofeedback; pulmonary function tests (FEV1, FVC, FEV1/FVC) conducted with spirometry; thoracic expansion measured at three levels using a tape-measure chest mobility test; and health-related quality of life evaluated with the St. George's Respiratory Questionnaire (SGRQ). The study protocol was approved by the Istanbul Medipol University Non-Interventional Clinical Research Ethics Committee.

This trial is designed to provide a comparative analysis of two commonly used physiotherapy interventions for FHP, with a focus on their effects on posture-related respiratory mechanics, thoracic mobility, and neuromuscular activation. All findings will be reported separately in the Results section. The present description outlines the scientific rationale, study design, and intervention procedures without duplicating eligibility criteria or outcome measure definitions.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

52

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 40 Jahre (Erwachsene)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Adults aged 18 to 40 years.
  • Craniovertebral angle (CVA < 53°) indicating forward head posture.
  • Able to perform exercise-based interventions.
  • Voluntarily agrees to participate and signs the informed consent form.
  • No neurological, orthopedic, systemic, or cardiopulmonary conditions that would limit participation.

Exclusion Criteria:

  • Contraindications to exercise (e.g., acute musculoskeletal injury, uncontrolled cardiovascular disease).
  • Chronic upper respiratory tract disease that may affect spirometry results. Presence of a cardiac pacemaker.
  • Neurological disorders, systemic diseases, or mental impairments that could interfere with exercise cooperation.
  • History of orthopedic or musculoskeletal surgery affecting mobility or posture.
  • Currently participating in respiratory exercises, spinal stabilization training, or structured exercise programs.
  • Engagement in professional sports or intensive physical training that may affect baseline neuromuscular measurements.
  • Failure to comply with the exercise program (e.g., missing 3 consecutive days of prescribed exercises).

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Dynamic Neuromuscular Stabilization Group (DNSG)

Developmental DNS patterns (supine 90/90, prone on elbows, quadruped), performed twice daily for 6 weeks.

Participants in the DNS group will perform Dynamic Neuromuscular Stabilization exercises based on developmental kinesiology principles. The program consists of three standardized DNS patterns:

Supine 90°/90° Position (4.5-month developmental stage): The participant lies supine with hips and knees flexed to 90°, emphasizing diaphragmatic breathing, rib cage expansion, and neutral spine alignment.

Prone on Elbows (4.5-month stage): The participant supports the upper body on elbows while maintaining cervical neutrality and coordinated diaphragmatic breathing.

Quadruped Position (9-month developmental stage): The participant maintains a four-point kneeling position with proper spinal stabilization and controlled breathing.

All exercises focus on coordinated activation of deep cervical flexors, diaphragm, transversus abdominis, multifidus, and pelvic floor muscles.

Participants will perform 2 supervised sessions per week and twice-daily home exercises (10 repetitions × 3 sets) for 6 weeks.

Experimental: Thoracic Expansion Exercise Group (TEG)

Upper, middle, and lower lobe-focused thoracic expansion breathing exercises, twice daily for 6 weeks.

Participants in the thoracic expansion group will perform a structured breathing exercise program focused on increasing upper, middle, and lower thoracic mobility. The program includes:

Upper Lobe Expansion Exercise: Participant places hands over upper thoracic region and performs deep inhalation to expand upper lung fields, followed by slow exhalation.

Middle Lobe Expansion Exercise: Hands placed laterally at mid-thoracic level to facilitate expansion of the middle lobes during inhalation.

Lower Lobe Expansion Exercise: Hands positioned over the lower rib cage to promote diaphragmatic and lower thoracic expansion.

Each exercise is performed for 3 sets of 10 repetitions, twice daily, for 6 weeks. Two supervised sessions per week will ensure correct technique and progression. The exercises aim to improve thoracic mobility, respiratory mechanics, and chest wall expansion.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Craniovertebral Angle (CVA)
Zeitfenster: Baseline and Week 6

CVA is used to assess forward head posture. Participants will be asked to stand in a natural and relaxed posture while focusing on a marked point at eye level on the wall. A lateral photograph will be taken using a Iphone 13 camera mounted on a tripod at shoulder height and placed 1.5 meters from the participant. The spinous process of the C7 vertebra and the tragus of the ear will be marked. The angle between the line connecting the tragus to C7 and a horizontal reference line will be calculated using the ImageJ software. The measurement results will be recorded on the evaluation form.

Analysis Metric: Change in CVA (degrees)

Baseline and Week 6

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Trapezius Muscle Activity (Surface EMG Biofeedback, µV)
Zeitfenster: Baseline and Week 6

Surface EMG sensors will be placed bilaterally over the upper trapezius muscles. Participants will perform three 5-second isometric contractions, and the mean amplitude (µV) of the signals will be recorded.

Analysis metric: Change from baseline to Week 6 in mean EMG amplitude of bilateral upper trapezius

Baseline and Week 6
FEV1 (Forced Expiratory Volume in 1 Second)
Zeitfenster: Baseline and Week 6

FEV1 will be recorded using a portable spirometer (BTL-08 Spiro Pro). The highest value of three acceptable forced expiratory maneuvers will be used.

Analysis Metric: Change from baseline to Week 6 (liters)

Baseline and Week 6
FVC (Forced Vital Capacity)
Zeitfenster: Baseline and Week 6

FVC will be assessed using standard spirometry procedures. Three maximal forced expiratory maneuvers will be performed, and the best value will be recorded.

Analysis Metric:

Change from baseline to Week 6 (liters)

Baseline and Week 6
Thoracic Expansion (Chest Mobility, cm)
Zeitfenster: Baseline and Week 6

Thoracic expansion will be measured with a tape measure at upper, middle, and lower thoracic levels. The difference between maximum inhalation and exhalation will be used as the thoracic mobility value.

Analysis Metric:

Change from baseline to Week 6 (cm)

Baseline and Week 6
St. George's Respiratory Questionnaire (SGRQ) Total Score
Zeitfenster: Baseline and Week 6

The SGRQ is a standardized instrument assessing symptoms, activity limitation, and psychosocial impact related to respiratory dysfunction. Scores range from 0 to 100, with higher scores indicating worse health status and greater impairment.

Analysis Metric:

Change from baseline to Week 6 (0-100 score)

Baseline and Week 6

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Studienleiter: Gülay Yalçın, PhD, Mudanya University, Faculty of Health Sciences, Department of Physiotherapy
  • Hauptermittler: Esra Beceni, Lecturer, Mudanya University Vocational, Physiotherapy Program

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. Dezember 2025

Primärer Abschluss (Tatsächlich)

1. Mai 2026

Studienabschluss (Tatsächlich)

31. Mai 2026

Studienanmeldedaten

Zuerst eingereicht

16. November 2025

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

16. November 2025

Zuerst gepostet (Tatsächlich)

20. November 2025

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

6. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

4. November 2026

Zuletzt verifiziert

1. November 2025

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren